Vaccination with a shared oncogenic tumor-self antigen elicits a population of CD8+ T cells with a regulatory phenotype

Cancer immunotherapy is a powerful tool for inducing antigen-specific antitumor cytotoxic T lymphocytes (CTLs). Next-generation strategies may include vaccination against overexpressed oncogenic tumor-self antigens. Previously, we reported vaccination against the oncogenic tumor-self antigen D52 (D5...

Descripción completa

Detalles Bibliográficos
Autores principales: Elizondo, C. Riccay, Bright, Jennifer D., Bright, Robert K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Immunotherapeutics – Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746449/
https://www.ncbi.nlm.nih.gov/pubmed/36069634
http://dx.doi.org/10.1080/21645515.2022.2108656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746449/
https://www.ncbi.nlm.nih.gov/pubmed/36069634
http://dx.doi.org/10.1080/21645515.2022.2108656

Ejemplares similares